Skip to main content

Bisoprolol Fumarate and Hydrochlorothiazide

NDC 72578-113 · Viona Pharmaceuticals Inc

Generic namebisoprolol fumarate and hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE
Strength2.5; 6.25 mg/1; mg/1
Pharmacologic classAdrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]
Marketing categoryANDA

Packages

72578-113-01 — 100 TABLET, FILM COATED in 1 BOTTLE (72578-113-01)

72578-113-05 — 500 TABLET, FILM COATED in 1 BOTTLE (72578-113-05)

72578-113-06 — 30 TABLET, FILM COATED in 1 BOTTLE (72578-113-06)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

72189-326 — losartan potassium and hydrochlorothiazide, 72189-327 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 72189-513 — Hydrochlorothiazide, 72189-651 — Lisinopril/HCTZ, 72205-147 — olmesartan medoxomil-hydrochlorothiazide, 72205-148 — olmesartan medoxomil-hydrochlorothiazide, 72205-149 — olmesartan medoxomil-hydrochlorothiazide, 72578-090 — Triamterene and Hydrochlorothiazide, 72578-111 — Bisoprolol Fumarate, 72578-112 — Bisoprolol Fumarate, 72578-114 — bisoprolol fumarate and hydrochlorothiazide, 72578-115 — bisoprolol fumarate and hydrochlorothiazide, 72603-290 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 72603-291 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 72603-292 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 72789-162 — losartan potassium and hydrochlorothiazide, 72789-176 — Hydrochlorothiazide, 72789-183 — Triamterene and Hydrochlorothiazide, 72789-296 — Hydrochlorothiazide, 72789-303 — Hydrochlorothiazide, +903 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels